Integral Diagnostics (Integral Diagnostics) Total Stockholders Equity : $201.1 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Integral Diagnostics Total Stockholders Equity?

Integral Diagnostics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $201.1 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Integral Diagnostics's Book Value per Share for the quarter that ended in Dec. 2023 was $0.86. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Integral Diagnostics's Debt-to-Equity for the quarter that ended in Dec. 2023 was 1.20.

Integral Diagnostics Total Stockholders Equity Historical Data

The historical data trend for Integral Diagnostics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integral Diagnostics Total Stockholders Equity Chart

Integral Diagnostics Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Stockholders Equity

Get a 7-Day Free Trial

88.35

157.58

194.76

244.02

250.37

Integral Diagnostics Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial												190.99	244.02	250.03	250.37	201.05

Integral Diagnostics (OTCPK:ITGDF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Integral Diagnostics's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(201.054	-	0)	/	233.424
	=	0.86

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Integral Diagnostics's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(11.97	+	229.993)	/	201.054
	=	1.20

Integral Diagnostics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Integral Diagnostics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Integral Diagnostics (Integral Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integral Diagnostics Ltd (OTCPK:ITGDF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

IDX:Australia

Address

45 William Street, Suite 9.02, Level 9, Melbourne, VIC, AUS, 3000

Website

http://www.integraldiagnostics.com.au

Integral Diagnostics is Australia's fourth-largest diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.